Caliway Biopharmaceuticals Co., Ltd. (TPE:6919)
104.00
+3.00 (2.97%)
May 8, 2026, 1:30 PM CST
48.15% (1Y)
| Market Cap | 161.86B +34.7% |
| Revenue (ttm) | 38.04M -6.0% |
| Net Income | -284.11M |
| EPS | -0.18 |
| Shares Out | 1.56B |
| PE Ratio | n/a |
| Forward PE | 33.41 |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 5,258,861 |
| Average Volume | 7,754,391 |
| Open | 103.00 |
| Previous Close | 101.00 |
| Day's Range | 101.50 - 105.00 |
| 52-Week Range | 69.90 - 277.00 |
| Beta | 1.28 |
| RSI | 47.79 |
| Earnings Date | Aug 10, 2026 |